Thrombosis
From the Journals
Post–COVID vaccine AHA cases raise eyebrows in Italy
Four cases of acquired hemophilia A that occurred following COVID-19 vaccinations in one Italian province could indicate “possible complications...
Conference Coverage
New hemophilia treatments: ‘Our cup runneth over’
A range of new options is emerging to treat hemophilia patients.
Conference Coverage
New stroke risk score developed for COVID patients
The user-friendly score represents a step forward but also points to the need to better risk-stratify patients for this complex, expensive, and...
Feature
Novel drug targets raised Lp(a): topline results released
Significant reductions in lipoprotein(a) were sustained out to 150 days in patients without cardiovascular disease in top-line phase 1 results...
From the Journals
Seniors face higher risk of other medical conditions after COVID-19
The risk of a new condition being triggered by COVID is more than twice as high in seniors, compared with younger patients, new research suggests...
From the Journals
Ischemic stroke rates higher in young women than young men
Young women may be at a higher risk of ischemic stroke than young men, representing a “significant departure from our current scientific...
Feature
CVS Caremark formulary change freezes out apixaban
The decision doesn’t affect patients on a Medicare or Medicaid plan but hits those taking the popular anticoagulant who have select commercial...
From the Journals
Who benefits most from device PFO closure after a stroke?
Younger patients with high-risk physiological features but no vascular risk factors may benefit most from patent foramen ovale closure with a...
News from the FDA/CDC
CDC panel backs mRNA COVID vaccines over J&J because of clot risk
The risk of dying from TTS after a Johnson & Johnson shot is extremely rare.
Guidelines
ACC, AHA issue new coronary revascularization guideline
The clinical practice guideline calls for greater equity in patient care and tackles the timely issues of revascularization in stable ischemic...
From the Journals
Apixaban outmatches rivaroxaban for VTE in study
These real-world findings may guide selection of initial anticoagulant therapy, according to authors of the paper.